CRISPR Therapeutics AG
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $2.27B
Liabilities Breakdown FY2025
Total Liabilities: $343.4M
Asset Breakdown
Total Assets: $2.27B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $347.6M | 15.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $115.9M | 5.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.80B | 79.5% |
Liabilities Breakdown
Total Liabilities: $343.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.1M | 3.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $332.3M | 96.8% |